# Octreotide Acetate

NDC: 71288-566
Generic name: Octreotide Acetate
Labeler / Manufacturer: Meitheal Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20250228

FDA application: ANDA075957

## Active ingredients

- OCTREOTIDE ACETATE: 50 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-566"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-566
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01962c67-e551-47b6-a276-e1ae1860d2a4